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Background: The primary purpose of this study is to examine whether use of source data is effective in increasing the
number of arterial segments that can be interpreted from maximum intensity projections of lower limb MR angiograms.
Correlation between sites of arterial disease and venous contamination was also measured. Interpretation of source data
is performed routinely by radiologists, but the value of this has not been well studied with randomized studies.
Results: The proportion of segments visible above the knee was 87% using maximal intensity projection alone (MIP)
and 88% when the MIP was combined with source data. The proportions were 67% for MIP and 72% for MIP plus
source data below the knee. There was substantial agreement between presence of arterial disease and venous
contamination in the calf and thigh.
Conclusion: The use of source data increases the number of assessable segments, but not individuals, by a statistically
significant but small amount (1.2%, p <0.05). This study supports the association between arterial disease and venous
contamination.
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Contrast–enhanced magnetic resonance angiography (CE-
MRA) of the lower limbs has high sensitivity and specifi-
city and is an alternative to conventional angiography
[1,2]. A recent meta-analysis of lower limb MRA indicates
a high degree of accuracy in the assessment of stenoses
[3]. The prevalence of asymptomatic peripheral arterial
disease lies between 3% and 10% in the general popula-
tion, increasing to 15% to 20% in persons older than
70 years. The incidence of critical limb ischaemia (CLI) is
lower. There are approximately between 500 and 1000
new cases of CLI every year in a European or North
American population of 1 million [4].
One of the strengths of CE-MRA is that overview
maximum intensity projections (MIPs) of the subtracted
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unless otherwise stated.line at acquisition time and display the vasculature with-
out overlying structures. The role of source data in inter-
pretation is not well defined. Review of the source data
acquired at MRA has been used to improve assessment
of the degree of arterial stenoses [5]. The accuracy of
vessel diameter assessment from a MIP is dependent on
the spatial resolution of the source data [6,7]. Source
data can also be important in preventing misinterpret-
ation of artefacts arising from contrast-enhanced MRA
of the lower limbs [8].
Another potential use of source data is to assist in the
interpretation of arteries obscured by venous contamin-
ation on the overview MIPs. Early studies reported ven-
ous contamination to be present in 8-20% of studies
[1,9,10]. This artefact obscures the arteries on overview
MIP images and has limited the acceptability of the
technique. Despite improvements in MR scanner per-
formance and MRA techniques during the last decade,
venous contamination continues to limit this method.
Even with measurement of aorta to lower limb transittd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Typical acquisition parameters for automatic
stepping table peripheral CE-MRA: (Gradients: maximum
amplitude 23mT/m, slew rate 17mT/m/ms)
Abdomen Thigh Calf
TR (ms) 7.5 7.5 7.5
TE (ms) 2.3 2.3 2.3
Flip angle 35 35 35
FOV (cm) 430 430 430
Slice thickness (mm) 1.7 1.7 1.7
No. of slices 50 50 50
Frequency encoding 464 464 464
Phase encoding 128 128 128
NEX 1 1 1
Phase FOV 75% 75% 75%
K space ordering Reverse centric Low High Low High
Spatial resolution 0.84×0.84×1.7 0.84×0.84×1.7 0.84×0.84×1.7
Imaging time (sec) 21 21 21
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thigh compression, venous contamination is not entirely
eliminated [11].
The primary purpose of this study was to examine
whether use of source data is effective in increasing the
number of arterial segments that can be interpreted
from MIPs at peripheral MRA.
Method
This study was performed in compliance with the
2008 Helsinki Declaration [12] with the approval of
the Lincolnshire local research ethics committee
(protocol 320).
Over a five month period 36 consecutive patients were
enrolled into the study. All patients had a history of
claudication of less than 100 yards or critical ischaemia
(rest pain or tissue loss). The MR exclusion criteria were
standard contra-indications to MR imaging. Patients
were screened using a questionnaire for pacemaker or
defibrillator, heart valves, cerebral aneurysm clips, stents,
metallic implants or joints, pain relief patches, electronic
devices, metal dentures, shunts, tattoos or permanent
eyeliner, hearing aid or cochlear implant, hairpiece, body
piercings, operations on head or heart, surgery in the
last 3 months, diabetes, renal disease or asthma, bullets
or shrapnel, pellets or metallic fragments and metal frag-
ments in the eyes.
Of 36 patients, 4 patients were excluded from MRI
scanning at time of consenting. Two had pacemakers, 1
was claustrophobic and 1 patient was judged unfit to
give informed consent.
MR Technique
MRA was performed on a Philips 1.0 T unit (Philips NT,
Philips Healthcare, Guildford, UK) with automated step-
ping table. Patients were positioned on the MR table feet
first and the feet supported in a foot rest. A 20G cannula
was inserted into the ante-cubital fossa and flushed through
20 cm of connecting tubing with normal saline. After ac-
quisition of planner scans at 3 stations using the in-built
body coil, 3D spoiled gradient echo angiography masks
were performed. A mask of the lower legs using 2 anterior
elements of the phased array surface coil and then masks of
the upper legs and finally of the pelvis using the inbuilt
body coil were performed. The pelvis was scanned as a
breath-hold. The angiographic sequences were repeated
during infusion of triple dose (0.3 mmol/kg body weight) of
intravenous gadopentetate dimeglumine (Magnevist, Bayer
Healthcare Pharmaceuticals, Wayne, NJ). The contrast
agent infusion at 1 ml/second was followed by an equal vol-
ume of normal saline at 1 ml/second. Imaging was initiated
during a bolus tracking MR fluoroscopic sequence when
contrast medium was detected at the aortic bifurcation.
Breath hold pelvic imaging was followed by upper leg andthen calf acquisitions with 2 table movements of 4 seconds
each. The total length of the scan including table move-
ment was chosen to enable appropriate spatial resolution
but did not exceed 70 seconds. Maximum slice thickness
was 2 mm. Acquisition parameters are shown (Table 1).
At the time of each study the interval between com-
mencement of intravenous infusion of contrast agent and
time of arrival at the aortic bifurcation was recorded.
Conventional Angiography (CA)
CA was performed on a Philips MD3 unit with 4 F pigtail
placed in the distal aorta 2–3 cms above the iliac bifur-
cation. Pump injection of up to a maximum of 65 mls of
intravenous contrast agent (300 mg iodine/ml) was per-
formed at a rate of 8 ml/sec using bolus chase run images.
AP views from aortic bifurcation to the foot arch or as far
distally as possible. 30 degree oblique views of the pelvis
were also performed when indicated.
CA and MRA were performed within 5 days of each
other. Patients were invited to participate in the study at
time of consultation when conventional angiography was
proposed. An information document was provided if pa-
tients expressed willingness to participate and formal
witnessed consent was obtained prior to MRA study. If
radiological intervention was intended, MRA was per-
formed prior to the conventional angiogram.
Analysis
The conventional angiograms were performed and re-
ported by an interventional radiologist of 6 years’ experi-
ence (KG).
Each MRA study was reviewed at a workstation by a
radiologist with 4 years’ experience with special interest
in performance and interpretation of MRA (PNM).
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aorta, common iliac, external iliac, common femoral,
origin of profunda femoris, superficial femoral (upper,
middle and lower segments), popliteal artery (above and
below knee), common peroneal artery, anterior and pos-
terior tibial and peroneal ateries (proximal and distal
segments). Each segment was assessed for both legs.
Visualised segments were scored as ≤50% stenosis or
51-99% stenosis. The arterial segments not visible were
described as not seen (NS). For MRA studies a category
of ‘not seen because of venous contamination’ (NSVC)
was used if non-visualisation was for this reason.
For MRA, the MIP study was reviewed first without
reference to source data, but with knowledge of the clin-
ical information.
Following the MIP review, assessment of stenoses and
visualization of each segment was repeated using MIP
reformats and unsubtracted source data together.
Statistics
The number of segments visualised by each technique
was compared. The number of visualised segments
(stenoses of ≤ 50% and 51-99%) both above and belowTable 2 Demonstration of arterial disease by MRA MIP, MRA M
agreement, using quadratic weighting, between the angiograp
intervals: 0.63-0.73)
MRA (MIP Only)
≤ 50% 51-99%
Stenosis
NS NSVC ≤
Stenosis St
Infra-renal aorta 32 0 0 0
Common iliac 60 2 2 0
Internal iliac-origin 55 4 4 1
External iliac 62 1 1 0
Common fem 61 1 2 0
Profunda fem 56 5 3 0
Superficial fem-up1/3 37 8 15 4
Superficial fem-mid1/3 35 8 17 4
Superficial fem-low1/3 41 11 12 0
Popliteal-AK 49 3 12 0
Popliteal-BK 55 2 7 0
Ant tib-horizontal 44 3 14 3
Ant tib-vert-prox 50% 36 3 21 4
Ant tib-vert - dist 50% 34 1 24 5
Common peroneal 45 5 8 6
Post Tib - prox 50% 36 4 21 3
Post Tib – dist 50% 27 2 27 8
Peroneal - prox 50% 49 3 8 4
Peroneal - dist 50% 39 0 16 9
NS – Segment not seen. NSVC – Segment not seen because of venous contaminati
CA – Conventional angiography.the knee using MIP alone was compared with MIP com-
bined with source data using McNemar’s test for paired
proportions. Statistics were run with individual patients
assessed as end-points for statistical significance and also
as individual arterial segments. Correlation between ven-
ous contamination and arterial disease was measured
using Cohen’s kappa coefficient of agreement. The mean
transit times between patients with venous contamin-
ation and patients without venous contamination were
documented with descriptive statistics. All analyses were
carried out using MedCalc 12.0 (Mariakerke, Belgium).
Results
Data from 32 patients were obtained. Fourteen patients
were male and 18 were female. The mean age was
74 years (range 48 to 89 years). Nine were diabetic.
1184 segments in 32 patients were assessed by CA and
MRA. The number of segments above the knee and
below the knee joint that were patent (0-50%, 51-99%),
NS and NSVC was recorded for both the MIP only and
MIP plus source data MRA (Table 2).
The proportion of arterial segments visible is shown
(Table 3). The proportion visible above the knee wasIP & base data and CA by segment: kappa coefficient of
hic and MR measures of stenosis, k = 0.68 (95% confidence
MRA (MIP& BD) CA
50% 51-99%
Stenosis
NS NSVC ≤ 50% 51-99%
Stenosis
NS
enosis
32 0 0 0 32 0 0
60 1 3 0 62 2 0
55 5 4 0 56 4 4
63 0 1 0 60 2 2
61 1 2 0 61 0 3
57 4 3 0 59 4 1
42 6 15 1 44 6 14
38 9 15 2 39 7 18
41 10 13 0 37 10 17
49 3 12 0 43 7 14
54 3 7 0 53 2 9
47 2 12 3 44 6 14
38 4 19 3 31 8 25
37 1 23 3 30 1 33
45 6 8 5 46 6 12
40 6 16 2 34 7 23
33 3 22 6 30 1 33
50 3 7 4 47 6 11
41 0 15 8 49 0 15
on.
Table 3 Visualisation of arterial segments: Summary for
all methods above and below the knee joint
≤ 50%
Stenosis
51-99%
Stenosis
NS NSVC % of total
segments
assessable
Above
knee
MIP only 488 43 68 9 87%
MIP/source
data
498 39 68 3 88%
Conv Angio 493 42 73 0 88%
Below
knee
MIP only 365 23 146 42 67%
MIP/source
data
385 28 129 34 72%
Conv Angio 364 37 174 0 70%
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source data). The proportions were 67% for MRA (MIP
only) and 72% for MRA (MIP & source data) below the
knee. These findings were very similar to the proportions
of segments assessable at CA, 88% above and 70% below
the knee. The kappa coefficient of agreement, using quad-
ratic weighting, between the angiographic and MR mea-
sures of stenosis was k = 0.68 (95% confidence intervals:
0.63-0.73) indicating “substantial” agreement [13].
The proportion of segments not visible because of VC
using MIP images alone was 1.5% above the knee and
7.3% below the knee. When both MIP and source data
were read, the proportion was 0.5% above the knee and
5.9% below the knee (Figure 1). These differences in pro-
portions interpretable were significant for all segments
considered together (P < 0.001) and when below knee
segments (P = 0.008) were assessed separately to above
the knee (P = 0.03). (Tables 4, 5 and 6). When comparing
MIP and MIP/source data readings for an individual pa-
tient (n = 32), the differences are not statistically signifi-
cant (above knee p = 0.06, below knee p = 1.0).Figure 1 75 year old male diabetic with dusky feet and ulcer on right
(b) Source data shows the right peroneal artery with greater clarity but theSites of venous contamination were compared with
sites of arterial disease and the transit time from start of
injection to the iliac arteries. Venous contamination and
arterial disease were most prevalent in the calf segments,
where they affected 63% and 75% of segments respect-
ively. The pelvic segments were least affected, with VC
only visible in one segment (3.1%) and arterial disease
present in three segments (9.4%) (Table 7). Cohen’s
kappa coefficient of agreement between the presence of
arterial disease and VC was κ = 0.69 (95% CI: 0.55-0.83)
which corresponds to “substantial agreement” [13].
The transit time for patients with VC (n = 28) was
22.1 s (SD 4.1) and the mean transit time for patient
with no VC (n = 4) was 29.25 s (SD 6.5). The small num-
bers of patients with no VC meant that no meaningful
statistical comparison was possible (Figure 2).
Discussion
Since the introduction of contrast-enhanced MRA of the
lower limbs, there have been several advances which
have reduced the severity of venous contamination. In-
creases in gradient strength and multi-element array
coils have enabled more rapid image acquisition, with
greater signal and spatial resolution. Parallel imaging has
also reduced acquisition times reducing venous contam-
ination [14].
Successful alternative strategies to optimize the time
of scanning of the calf and so reduce venous contamin-
ation in the calf have been used. These include bolus
timing injection to predict the interval between starting
infusion and arrival time at the calf [15], or the use of
dual injection techniques with scanning of the calf be-
fore the upper stations [16]. Time resolved imaging of
the calf [17] or the use of subsystolic thigh compression
which increases the arterio-venous transit time [18,19]foot. (a) MIP of diseased calf run-off with venous contamination.
same information was elicited form the MIP.
Table 4 Contingency table comparing MIP with MIP +
source data for all lower limb assessable segments
demonstrating a small but significant difference in
proportions
MIP MIP and source data Total
Assessable NSVC
Assessable 1133 0 1133
NSVC 14 37 51
Total 1147 37 1184
Difference of proportions
(95% confidence intervals)
−0.012 (−0.012 to −0.006)
Two-tailed p (McNemar) 0.0001
Table 6 Contingency table comparing MIP with MIP +
source data for assessable segments below the knee
demonstrating a small but significant difference in
proportions
MIP and source data Total
MIP Assessable NSVC
Assessable 534 0 534
NSVC 8 34 42
Total 542 34 576
Difference of proportions
(95% confidence intervals)
−0.014 (−0.014 to −0.004)
Two-tailed p (McNemar) 0.008
Table 7 Contingency tables describing the relationship
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high field strength and multi-element receiver coils sub-
stantially reduce the drawbacks of MRA and have gener-
ated a resurgence of interest in non-contrast MRA
[20,21]. However even the use of a timing bolus, thigh
compression and optimization of scan parameters on
state of the art hardware do not entirely eliminate ven-
ous contamination during 3 station bolus chase acquisi-
tion [11]. The use of blood pool contrast agents is
currently limited by cost and availability but these agents
prolong the intravascular residence time. This enables
higher resolution scanning which reduces partial volume
effects and improves separation of arterial and venous
structures on base data [22].
This study has focused on the value of reviewing the
source data but additionally demonstrated that CE-MRA
at 1.0 T was able to assess an equivalent number of ar-
terial segments to CA, both with and without the use of
source data. There was also substantial agreement for
the assessment of stenoses for the two techniques.
It is evident that venous contamination will obscure
arterial signal on MIP images because these structures
are adjacent and may be superimposed. However venous
contamination can make visualization of the arteries dif-
ficult even on base data because the strongest predictor
of venous contamination is arterial disease [14] and so
venous contamination is likely to occur when theTable 5 Contingency table comparing MIP with MIP +
source data for assessable segments above the knee
demonstrating no significant difference in proportions
MIP and source data Total
MIP Assessable NSVC
Assessable 599 0 599
NSVC 6 3 9
Total 605 3 608
Difference in proportions
(95% confidence intervals)
−0.010 (−0.010 to −0.001)
Two-tailed p (McNemar) 0.031arteries are most difficult to see, because of local ather-
omatous disease or poor flow because of more proximal
disease. Diabetes mellitus, cellulitis and osteomyelitis re-
sult in faster flow to the calf [15], and it is proposed that
inflammatory processes increase the speed of arterio-
venous transit by reducing arteriolar resistance [14]. This
effect is magnified in this series because of the relative
severity of disease in this group. All patients had a
history of claudication of less than 100 yards or critical
ischaemia (rest pain or tissue loss). Poor run-off resulted
in segments that could not be assessed at either CA
or MRA.
In this study there is substantial agreement between
the angiographic, MIP only and MIP/BD techniques for
assessment of stenosis/occlusion. More arterial segments
are seen when viewing MIP/source data compared with
MIP only. Statistical significance (p <0.05) was found
both above and below the knee, although the proportion
of segments overall affected was small.
While the difference in proportions for all segments is
statistically significant we do not have good evidence that
routine use of base data is required for increasing the
number of visualized segments or to improve stenosis as-
sessment. MR technology also continues to evolve rapidly
and any advantage to use of source data in this context isbetween venous contamination and arterial disease in
the pelvis, thigh and calf
Region Diseased VC No VC κ* 95% confidence intervals
Calf Yes 19 5 0.57 (0.28-0.87)
No 1 7
Thigh Yes 20 5 0.446 (0.10-0.79)
No 2 5
Pelvis Yes 1 2 0.48 (−0.12-1.0)
No 0 29
All Yes 40 12 0.69 (0.55-0.83)
No 3 41
*Cohen’s Kappa Agreement Co-efficient.
Figure 2 75 year old male diabetic with bilateral calf claudication. (a) Superficial femoral disease with venous contamination (b) Three
vessel run off and absence of venous contamination in the calf.
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ing techniques for reduction of venous contamination.
Novel MRA techniques, such as electrocardiographically-
triggered non-contrast-enhanced magnetic resonance angi-
ography (balanced 3D steady state free precession imaging)
may yet finally overcome the effect of venous contamin-
ation [23]. Alternatively use of a phase-contrast sequence
to determine the flow velocities prior to the acquisition of
systolic and diastolic spin echo images can provide subtrac-
tion arterial images.
There is data to indicate that the likelihood of venous
contamination is correlated with some characteristics of
the study population which determine the arterio-
venous window. This is the time between first visualisa-
tion of arterial contrast and the first visualization of
venous return in the lower limb [24]. Venous contamin-
ation appears to be a consequence of arterial disease
resulting in abnormal arterio-venous transit. This is
most commonly seen on more delayed scans of the calf
in moving table studies. It is due primarily to shortened
arterio-venous transit time in the presence of arterial
disease [24] and is compounded by the rapid transit time
between common femoral artery and ankle because tim-
ing of initiation of infusion, rate of the contrast agent
infusion and scan timing at each station using the step-
ping table technique are not always optimal [25].
This study supports the relationship between arterial
disease and venous contamination in the calf and thigh.The lack of significant relationship in the pelvis is likely to
reflect the small number of diseased segments (4/1184).
A limitation of this study is the review of CA and
MRA data by two single readers. However evidence
from recent meta-analysis of peripheral MRA studies
shows strong correlation between readers [3] suggesting
that this limitation is not likely to affect the findings.Conclusions
In conclusion, venous contamination affects a propor-
tion of arterial segments at CE-MRA. The number of
segments that can be assessed by review of the source
data is greater and this is statistically significant when
considering individual arterial segments, but not when
comparing individuals. Though use of base data may be
important in interpreting artefacts, there is no evidence
from this study to suggest that routine review of base
data is required for patency or degrees of stenosis when
interpretating contrast enhanced MRA of the peripheral
arteries. There is a significant relationship between the
anatomical level of arterial disease and venous contam-
ination, strengthening the suggestion of a causal rela-
tionship as previous studies have suggested.Abbreviations
MRI: Magnetic resonance imaging; VC: Venous contamination; MIP: Maximum
intensity projection; CA: Conventional angiography; SFA: Superficial femoral
artery; AK: Above knee; BK: Below knee.
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